Blis says full-year loss could hit $2.7m

Blis says full-year loss could hit $2.7m
Dunedin firm is still struggling through covid. (Image: supplied)
Staff reporters
Listed probiotics company Blis Technologies reported an earnings before interest, tax, depreciation and amortisation (ebidta) loss of $400,000 for the three months to Dec 31.This was on the back of a $100,000 dip in revenue to $2.3m – largely as a result of global covid impacts.The firm said in a statement to the NZX it expected to report a loss of between $2.3 million and $2.7m ebidta for the year to March 2022. Its existing market guidance is for revenue in a range between $8.6m and $9.1m, down at least $1.5m on the $10.6m reported...